PeopleBio Co Ltd
304840
Company Profile
Business description
PeopleBio Co Ltd is a biotechnology company. The company is engaged in the business of developing and manufacturing blood diagnostic products for variant protein diseases. The main product of the company is a blood test product that can be used for the early diagnosis of Alzheimer's disease, a representative degenerative brain disease. The company is also researching and developing products that can be applied to the diagnosis of various variant protein diseases, including degenerative brain diseases.
Contact
242 Pangyo-ro
6th Floor, Pangyo Digital Center, C-dong
Bundang-gu, Gyeonggi-do
Sampyeong-dong
Seongnam-si13487
KORT: +82 315267825
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
47
Stocks News & Analysis
stocks
Disney earnings: Experiences and streaming again drive excellent results
We believe Disney’s irreplaceable characters will continue to drive a healthy experiences business, which we estimate is worth nearly as much as the market values the whole firm.
stocks
ASX utility share downgraded as electricity prices fall
Falling electricity prices weigh on earnings outlook for utility provider.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,445.10 | 33.80 | 0.36% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 65,606.71 | 76.55 | -0.12% |
| NZX 50 Index | 13,824.13 | 133.93 | -0.96% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,263.60 | 34.80 | 0.38% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |